Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found. Results were reported in the study “Real-world durability of relapse rate reduction in patients with multiple… Read more »
Posts By: Karen Jones
Source Science Daily: Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans. Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s… Read more »
Are you a good listener? 100,000 people live with multiple sclerosis (MS) in the UK. Every one of them shares the uncertainty of life with MS. People are most likely to find out they have MS in their thirties, forties and fifties; news that can be scary and heart breaking. MS can get steadily worse,… Read more »
Martin’s funeral will be on Thursday 7th March at 1pm at South Oxfordshire Crematorium.
It is with great sadness that I have to report that two of our members have sadly passed away; Martin Johns and Joy Drake. Martin contracted a serious infection and had to be admitted to hospital where he sadly died. Funeral details will follow and Martin had requested that money from a collection at his funeral should go to the Centre. … Read more »
Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with neurons and the astrocytes that are essential to nerve cell health. These long-surviving… Read more »
Source MS Trust: A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS. Back in September, NICE announced that it would not be recommending ocrelizumab as an NHS treatment for early primary progressive MS…. Read more »
Source Independent Living: Exercise is frequently cited as a good way of helping to prevent falls, and now we have strong evidence that a programme of exercise can indeed prevent falls amongst older people living in the community. Falls are a leading cause of accidental or unintentional injury deaths worldwide. Older adults suffer the greatest number… Read more »
RA student PhD researcher at Loughborough University is conducting research about heat and cold in Multiple Sclerosis.Please share this link with your members so that they can complete if interested.https://lboro.onlinesurveys.ac.uk/temperature-sensitivity-in-multiple-sclerosis-online-survey1
If anyone would like to go to Ed’s funeral, it will be held on Monday 4th February, 1pm at Oxford Crem and after at the Windrush Pub, Burford Road, Witney.